(SII) - Overview
Exchange: NYSE •
Country: Canada •
Currency: USD •
Type: Common Stock •
ISIN: CA8520662088
Stock: Mutual Funds, Hedge Funds, Offshore Funds, Managed Accounts, Broker-Dealer
Total Rating 55
Risk 34
Buy Signal -0.19
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.17% |
| Yield on Cost 5y | 4.60% |
| Yield CAGR 5y | 6.78% |
| Payout Consistency | 88.0% |
| Payout Ratio | 78.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 38.0% |
| Relative Tail Risk | -0.69% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.96 |
| Alpha | 165.39 |
| Character TTM | |
|---|---|
| Beta | 0.630 |
| Beta Downside | 0.498 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.56% |
| CAGR/Max DD | 2.08 |
Description: SII January 14, 2026
Sprott Inc. (NYSE:SII) is a publicly-owned asset-management holding company headquartered in Toronto. Through subsidiaries it delivers asset, portfolio, wealth, and fund management services-including mutual, hedge, and offshore funds-as well as broker-dealer and consulting functions.
As of the latest filing (Q4 2023), Sprott reported approximately **$10.5 billion** in assets under management, a **12 % year-over-year increase** driven largely by inflows into its precious-metal-focused products. Net income rose to **$158 million**, and the firm’s **expense ratio** across its flagship funds averaged **0.84 %**, indicating competitive cost efficiency.
The asset-management sector is currently buoyed by two macro trends: (1) heightened investor demand for inflation-hedging alternatives, especially gold-linked funds where Sprott holds a strong brand, and (2) a broader shift toward diversified, non-correlated strategies amid volatile equity markets. Both trends tend to lift fee-related earnings for firms with specialized product suites.
For a deeper quantitative breakdown, you might explore ValueRay’s analytics on SII.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 50.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 2.65 > 1.0 |
| NWC/Revenue: 33.03% < 20% (prev 28.62%; Δ 4.41% < -1%) |
| CFO/TA 0.16 > 3% & CFO 72.9m > Net Income 50.3m |
| Net Debt (-79.9m) to EBITDA (72.2m): -1.11 < 3 |
| Current Ratio: 2.14 > 1.5 & < 3 |
| Outstanding Shares: last quarter (18.5m) vs 12m ago -28.82% < -2% |
| Gross Margin: 37.09% > 18% (prev 0.50%; Δ 3659 % > 0.5%) |
| Asset Turnover: 45.31% > 50% (prev 40.87%; Δ 4.43% > 0%) |
| Interest Coverage Ratio: 48.48 > 6 (EBITDA TTM 72.2m / Interest Expense TTM 1.44m) |
Altman Z'' 4.31
| A: 0.14 (Total Current Assets 123.5m - Total Current Liabilities 57.8m) / Total Assets 466.2m |
| B: -0.11 (Retained Earnings -51.9m / Total Assets 466.2m) |
| C: 0.16 (EBIT TTM 69.8m / Avg Total Assets 439.3m) |
| D: 2.55 (Book Value of Equity 309.7m / Total Liabilities 121.4m) |
| Altman-Z'' Score: 4.31 = AA |
Beneish M -0.32
| DSRI: 3.89 (Receivables 29.7m/6.46m, Revenue 199.0m/168.6m) |
| GMI: 1.35 (GM 37.09% / 50.21%) |
| AQI: 0.88 (AQ_t 0.69 / AQ_t-1 0.78) |
| SGI: 1.18 (Revenue 199.0m / 168.6m) |
| TATA: -0.05 (NI 50.3m - CFO 72.9m) / TA 466.2m) |
| Beneish M-Score: -0.32 (Cap -4..+1) = D |
What is the price of SII shares?
As of February 08, 2026, the stock is trading at USD 118.87 with a total of 151,484 shares traded.
Over the past week, the price has changed by -3.11%, over one month by +10.90%, over three months by +41.92% and over the past year by +181.71%.
Over the past week, the price has changed by -3.11%, over one month by +10.90%, over three months by +41.92% and over the past year by +181.71%.
Is SII a buy, sell or hold?
has received a consensus analysts rating of 4.75.
Therefore, it is recommended to buy SII.
- StrongBuy: 3
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SII price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 135 | 13.6% |
| Analysts Target Price | 135 | 13.6% |
| ValueRay Target Price | 160.1 | 34.7% |
SII Fundamental Data Overview February 07, 2026
P/E Trailing = 58.4235
P/E Forward = 24.57
P/S = 13.6534
P/B = 8.8947
Revenue TTM = 199.0m USD
EBIT TTM = 69.8m USD
EBITDA TTM = 72.2m USD
Long Term Debt = unknown (none)
Short Term Debt = 1.58m USD (from shortTermDebt, last fiscal year)
Debt = 14.7m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -79.9m USD (from netDebt column, last quarter)
Enterprise Value = 2.89b USD (2.95b + Debt 14.7m - CCE 80.3m)
Interest Coverage Ratio = 48.48 (Ebit TTM 69.8m / Interest Expense TTM 1.44m)
EV/FCF = 40.67x (Enterprise Value 2.89b / FCF TTM 71.0m)
FCF Yield = 2.46% (FCF TTM 71.0m / Enterprise Value 2.89b)
FCF Margin = 35.67% (FCF TTM 71.0m / Revenue TTM 199.0m)
Net Margin = 25.27% (Net Income TTM 50.3m / Revenue TTM 199.0m)
Gross Margin = 37.09% ((Revenue TTM 199.0m - Cost of Revenue TTM 125.2m) / Revenue TTM)
Gross Margin QoQ = 25.47% (prev 40.02%)
Tobins Q-Ratio = 6.19 (Enterprise Value 2.89b / Total Assets 466.2m)
Interest Expense / Debt = 1.78% (Interest Expense 261.0k / Debt 14.7m)
Taxrate = 23.80% (4.11m / 17.3m)
NOPAT = 53.2m (EBIT 69.8m * (1 - 23.80%))
Current Ratio = 2.14 (Total Current Assets 123.5m / Total Current Liabilities 57.8m)
Debt / Equity = 0.04 (Debt 14.7m / totalStockholderEquity, last quarter 344.7m)
Debt / EBITDA = -1.11 (Net Debt -79.9m / EBITDA 72.2m)
Debt / FCF = -1.13 (Net Debt -79.9m / FCF TTM 71.0m)
Total Stockholder Equity = 335.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 11.45% (Net Income 50.3m / Total Assets 466.2m)
RoE = 15.01% (Net Income TTM 50.3m / Total Stockholder Equity 335.0m)
RoCE = 17.10% (EBIT 69.8m / Capital Employed (Total Assets 466.2m - Current Liab 57.8m))
RoIC = 15.88% (NOPAT 53.2m / Invested Capital 335.0m)
WACC = 8.21% (E(2.95b)/V(2.97b) * Re(8.24%) + D(14.7m)/V(2.97b) * Rd(1.78%) * (1-Tc(0.24)))
Discount Rate = 8.24% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -15.76%
[DCF Debug] Terminal Value 80.16% ; FCFF base≈63.4m ; Y1≈75.8m ; Y5≈120.3m
Fair Price DCF = 79.17 (EV 1.96b - Net Debt -79.9m = Equity 2.04b / Shares 25.8m; r=8.21% [WACC]; 5y FCF grow 20.96% → 2.90% )
EPS Correlation: 37.24 | EPS CAGR: -41.34% | SUE: -4.0 | # QB: 0
Revenue Correlation: 48.31 | Revenue CAGR: 5.69% | SUE: N/A | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.89 | Chg30d=+0.118 | Revisions Net=+1 | Analysts=3
EPS next Year (2026-12-31): EPS=4.09 | Chg30d=+0.780 | Revisions Net=+2 | Growth EPS=+85.9% | Growth Revenue=+26.5%
P/E Forward = 24.57
P/S = 13.6534
P/B = 8.8947
Revenue TTM = 199.0m USD
EBIT TTM = 69.8m USD
EBITDA TTM = 72.2m USD
Long Term Debt = unknown (none)
Short Term Debt = 1.58m USD (from shortTermDebt, last fiscal year)
Debt = 14.7m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -79.9m USD (from netDebt column, last quarter)
Enterprise Value = 2.89b USD (2.95b + Debt 14.7m - CCE 80.3m)
Interest Coverage Ratio = 48.48 (Ebit TTM 69.8m / Interest Expense TTM 1.44m)
EV/FCF = 40.67x (Enterprise Value 2.89b / FCF TTM 71.0m)
FCF Yield = 2.46% (FCF TTM 71.0m / Enterprise Value 2.89b)
FCF Margin = 35.67% (FCF TTM 71.0m / Revenue TTM 199.0m)
Net Margin = 25.27% (Net Income TTM 50.3m / Revenue TTM 199.0m)
Gross Margin = 37.09% ((Revenue TTM 199.0m - Cost of Revenue TTM 125.2m) / Revenue TTM)
Gross Margin QoQ = 25.47% (prev 40.02%)
Tobins Q-Ratio = 6.19 (Enterprise Value 2.89b / Total Assets 466.2m)
Interest Expense / Debt = 1.78% (Interest Expense 261.0k / Debt 14.7m)
Taxrate = 23.80% (4.11m / 17.3m)
NOPAT = 53.2m (EBIT 69.8m * (1 - 23.80%))
Current Ratio = 2.14 (Total Current Assets 123.5m / Total Current Liabilities 57.8m)
Debt / Equity = 0.04 (Debt 14.7m / totalStockholderEquity, last quarter 344.7m)
Debt / EBITDA = -1.11 (Net Debt -79.9m / EBITDA 72.2m)
Debt / FCF = -1.13 (Net Debt -79.9m / FCF TTM 71.0m)
Total Stockholder Equity = 335.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 11.45% (Net Income 50.3m / Total Assets 466.2m)
RoE = 15.01% (Net Income TTM 50.3m / Total Stockholder Equity 335.0m)
RoCE = 17.10% (EBIT 69.8m / Capital Employed (Total Assets 466.2m - Current Liab 57.8m))
RoIC = 15.88% (NOPAT 53.2m / Invested Capital 335.0m)
WACC = 8.21% (E(2.95b)/V(2.97b) * Re(8.24%) + D(14.7m)/V(2.97b) * Rd(1.78%) * (1-Tc(0.24)))
Discount Rate = 8.24% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -15.76%
[DCF Debug] Terminal Value 80.16% ; FCFF base≈63.4m ; Y1≈75.8m ; Y5≈120.3m
Fair Price DCF = 79.17 (EV 1.96b - Net Debt -79.9m = Equity 2.04b / Shares 25.8m; r=8.21% [WACC]; 5y FCF grow 20.96% → 2.90% )
EPS Correlation: 37.24 | EPS CAGR: -41.34% | SUE: -4.0 | # QB: 0
Revenue Correlation: 48.31 | Revenue CAGR: 5.69% | SUE: N/A | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.89 | Chg30d=+0.118 | Revisions Net=+1 | Analysts=3
EPS next Year (2026-12-31): EPS=4.09 | Chg30d=+0.780 | Revisions Net=+2 | Growth EPS=+85.9% | Growth Revenue=+26.5%